Peptides Are Not Being Approved. They May Be Allowed. That Is Not the Same Thing.
Published on: 21/10/2026
An FDA peptide compounding policy is under review. It is not approval. What medspas need to know about BPC-157, enforcement discretion, and prescriber risk.
FDA peptidespeptide interim access policycompounded peptidesBPC-157BPC-157 legalpeptide therapy medspaenforcement discretion503A bulks listTB-500research use only peptidespeptide safetycompounding pharmacymedspa complianceunapproved drugsMedSpa Board

